The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.
This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,490 trial records at the last sync on 25 Sep 2026, 03:16 UTC; this register shows the 2,500 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.
This page shows the 12 of those trials with a site in Multiple sclerosis.
12 of the 2,500 most recently authorised trials in this register list a site in Multiple sclerosis; 3 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.
| Phase | Trials | Share |
|---|---|---|
| Phase II | 5 | 41.7% |
| Phase I | 3 | 25% |
| Phase III | 3 | 25% |
| Phase IV | 1 | 8.3% |
| Lead sponsor | Trials |
|---|---|
| Immunic AG | 3 |
| Amsterdam UMC Stichting | 1 |
| Aristotle University Of Thessaloniki | 1 |
| F. Hoffmann-La Roche AG | 1 |
| Region Stockholm – SLSO | 1 |
| Sanofi-Aventis Recherche & Developpement | 1 |
| Tg Therapeutics Inc. | 1 |
| Universitair Ziekenhuis Antwerpen, Hospital Germans Trias I Pujol | 1 |
| Varsinais-Suomen hyvinvointialue | 1 |
| Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy | 1 |